Compare STXS & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | OPRX |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 222.6M |
| IPO Year | 2004 | N/A |
| Metric | STXS | OPRX |
|---|---|---|
| Price | $2.68 | $11.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.00 | ★ $19.67 |
| AVG Volume (30 Days) | ★ 571.4K | 230.9K |
| Earning Date | 03-02-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $30,075,000.00 | ★ $109,506,000.00 |
| Revenue This Year | $24.21 | $19.77 |
| Revenue Next Year | $29.83 | $11.33 |
| P/E Ratio | ★ N/A | $6,535.19 |
| Revenue Growth | 19.62 | ★ 24.18 |
| 52 Week Low | $1.54 | $3.99 |
| 52 Week High | $3.59 | $22.25 |
| Indicator | STXS | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.60 | 39.02 |
| Support Level | $2.59 | $11.44 |
| Resistance Level | $2.82 | $12.34 |
| Average True Range (ATR) | 0.14 | 0.83 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 63.21 | 17.65 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.